Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System

Detalles Bibliográficos
Autores principales: Jones, S. Christopher, Ryan, Debra L., Pratt, Valerie S.W., Niak, Ali, Brinker, Allen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Departments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647172/
https://www.ncbi.nlm.nih.gov/pubmed/26597395
http://dx.doi.org/10.2337/diaspect.28.4.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647172/
https://www.ncbi.nlm.nih.gov/pubmed/26597395
http://dx.doi.org/10.2337/diaspect.28.4.283

Ejemplares similares